Skip to content

Clinical trials

Alzheimer Disease trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Taiwan Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20052
20081
20094
20103
20112
20125
20131
20146
20157
20166
20176
20186
20198
20209
20213
20225
20232
20245
202510
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Unknown status21
Recruiting17
Terminated13
Active, not recruiting4
Not yet recruiting3
Enrolling by invitation2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital20
National Taiwan University Hospital14
Eli Lilly and Company7
Hoffmann-La Roche6
China Medical University Hospital4
Chung Shan Medical University3
Novartis Pharmaceuticals3
Axovant Sciences Ltd.2
Biogen2
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease103
Dementia22
Cognitive Dysfunction21
Plaque, Amyloid8
Brain Diseases7
Neurodegenerative Diseases7
Nervous System Diseases5
Central Nervous System Diseases4
Dementia, Vascular4
Frontotemporal Dementia4

Trials

Showing 1 to 25 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.